FDA Inspection
ANI Pharmaceuticals Canada, Inc.ANI Pharmaceuticals Canada, Inc. – FDA Inspection, Jun 7, 2019
Record Details
This FDA Inspection record concerns ANI Pharmaceuticals Canada, Inc., with an inspection on June 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7612d98c-325a-4a89-9b8c-fa5716b8fedc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096666
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of ANI Pharmaceuticals Canada, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 17, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 9, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 24, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ANI Pharmaceuticals Canada, Inc.
- FDA Inspection 1197890 - 2023-02-17
- FDA Inspection 997351 - 2016-12-09
- FDA Inspection 866138 - 2014-01-24
- FDA Inspection 635624 - 2009-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.